CD4 and Parkinson disease: The present study found evidence supporting a potential causal relationship between the reduction in PD risk and higher serum TAG (51:4) levels and clarified the possible role of circulating immune cells (including IgD-CD38-B cell lymphocytes and resting CD4 regulatory T cell %CD4 + T cells), but not circulating inflammatory proteins.